Muhammad Khan
Internal Medicine · Las Cruces, NMNPI 1457791113
Payments from drug & device makers
Across 29 payments — averaging $29.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$496
- Cordis US CORP.$101
- Johnson & Johnson$70
- Novo Nordisk$44
- Tersera Therapeutics LLC$37
- Otsuka America Pharmaceutical, Inc.$22
- plus $75 from 4 others
What the payments were for
- Food & beverage$844100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 14 | $496 |
| Cordis US CORP. | 2 | $101 |
| Johnson & Johnson | 4 | $70 |
| Novo Nordisk | 3 | $44 |
| Tersera Therapeutics LLC | 1 | $37 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Boehringer Ingelheim | 1 | $22 |
| Boston Scientific | 1 | $21 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| AstraZeneca | 1 | $13 |
How this compares
$844 in reported general payments places this provider in the 85th percentile of 578 internal medicine providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 43 | $514 |
| Levothyroxine Sodium | 18 | $473 |
| Tamsulosin Hcl | 23 | $388 |
| Metoprolol Succinate | 23 | $329 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $257 |
| ClopidogrelClopidogrel Bisulfate | 13 | $200 |
| Montelukast Sodium | 13 | $186 |
| Rosuvastatin Calcium | 28 | $184 |
| Amlodipine Besylate | 18 | $162 |
| Lisinopril | 16 | $157 |
| Losartan Potassium | 27 | $86 |
| Metformin Hcl | 14 | $71 |
| Furosemide | 17 | $43 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Las Cruces
- Ann MercerLas Cruces$6K
- Sangeeth PaiLas Cruces$4K
- Syed AhmedLas Cruces$3K
- Azhar ZahirLas Cruces$3K
- Talha KhanLas Cruces$3K
- Jobin PhiliposeLas Cruces$2K
- Louis BeneventoLas Cruces$2K
- Edna JuarezLas Cruces$2K
- Michelle ValentineAlbuquerque$12.7M
- Linda GorgosSanta Fe$4.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.